Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Rachana K. Gandhi Mehta, MBBS, an assistant professor of neurology at Wake Forest School of Medicine, discussed a new, innovative trial assessing the therapeutic potential of self-administered subcutaneous rozanolixizumab as a treatment for myasthenia gravis.

Empowering Patients: Exploring Self-Administration of Rozanolixizumab for Myasthenia Gravis

Videos

The professor of neurology at the University of Alabama at Birmingham Epilepsy Center provided comment on raising awareness for infantile spasms, especially during Infantile Spams Awareness Week, which is celebrated the first week of December. [WATCH TIME: 3 minutes]

Important Considerations for Infantile Spasms Awareness: Martina Bebin, MD, MPA

QRL-201, developed by QurAlis, aims to restore STATHMIN-2 (STMN2) expression, a key protein for neural repair, which is significantly reduced in patients with ALS.

STATHMIN-Targeting Therapy QRL-201 Enters Dose Range-Finding Phase Following Successful PK Analysis

The vice chair of the American Academy of Sleep Medicine’s Clinical Practice Guidelines Task Force commented on some of the unanswered questions following the recently published guidelines for restless legs syndrome. [WATCH TIME: 3 minutes]

Exploring Gaps in RLS Treatment Through New 2024 Guidelines: Andy Berkowski, MD, PhD

The Association of Movement Disorder Advanced Practice Providers has launched its Certification of Movement & Related Disorder Specialist (CMRD) for advanced practice providers.

AMDAPP Launches Certification for Advanced Practice Providers in Movement Disorders

Here's the latest multidisciplinary multiple sclerosis (MS) research from the International Journal of MS Care.

Research from IJMSC November 2024

, has been with the team since September 2022. Follow her on Twitter 

The assistant professor of neurology at the Icahn School of Medicine at Mount Sinai provided an overview of a session on exercise and migraine presented at the 2024 Scottsdale Headache Symposium. [WATCH TIME: 5 minutes]

Overviewing Personalized Exercise Strategies for Migraine Management From AHS Scottsdale 2024: Anna Pace, MD

As part of our monthly clinician spotlight, NeurologyLive® highlighted epilepsy expert Stephanie C. Randle, MD, MS, director of the Tuberous Sclerosis Complex Clinic at Seattle Children's Hospital. 

NeurologyLive® Clinician of the Month Spotlight: Stephanie C. Randle, MD, MS

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AANEM 2024

CTAD 2024

MDS 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

Peers & Perspective page is a resource for sit-down video interviews between expert colleagues and peers on major topics in clinical practice and research.

1rem

Gabriel Pardo, MD, and Martin Belkin, DO, 

discuss how multiple sclerosis (MS) management now centers on detecting and mitigating progression independent of relapse activity (PIRA) through advanced biomarkers, early intervention, and personalized high-efficacy therapies targeting neurological preservation.

Investigating PIRA and Cognitive Functions in Multiple Sclerosis

Experts provide their clinical experience on identifying and managing smouldering multiple sclerosis, discussing the current treatment landscape and emerging approaches.

Expert Perspectives on the Management of Smouldering Multiple Sclerosis

Neurology experts discuss how patients with multiple sclerosis (MS) acquire disability and the concept of progression independent of relapse activity (PIRA). They also share recommendations on how to evaluate and care for cognitive decline and disease progression in patients with MS.

Disability Progression and Maintenance of Cognitive Function in Multiple Sclerosis

Experts in neurology discuss the use of oral therapies in the treatment of relapsing-remitting multiple sclerosis (MS). They discuss treatment selection based on long-term and real-world data and how recent and emerging therapies will change the management of patients with relapsing-remitting MS.

Updates in Current and Emerging Oral Treatment Options in Relapsing-Remitting Multiple Sclerosis

Advanced practice practitioners discuss the co-occurrence of sleep disorders with other health conditions, patient awareness, and the importance of screening for sleep disorders. They also discuss the treatment landscape of insomnia and the use of dual orexin receptor antagonists in the management of insomnia.

Advanced Practice Providers’ Perspectives on Sleep Disorders: Impact of Insomnia on Patient Health

Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age.

Multiple Sclerosis Care in Diverse Patient Populations: Challenges and Solutions

Expert neurologists review updates in the management of Myasthenia Gravis.

Updates in the Management of Myasthenia Gravis Peers and Perspectives

Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.

Optimizing Treatment of Relapsing-Remitting Multiple Sclerosis with Oral Therapies

Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.

Improving Diagnosis and Patient Outcomes in Narcolepsy

Expert neurologists examine strategies for optimizing treatment formulations in the management of OFF episodes in Parkinson disease and highlight the importance of patient education.

Practical Considerations in the Management of OFF-Episodes in Parkinson Disease

Recommendations to neurologists on appropriately prescribing and managing patients with relapsing-remitting multiple sclerosis using novel, oral therapies.

Oral Therapy Options for Relapsing-Remitting Multiple Sclerosis

Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.

Rare Childhood Epilepsies: Dravet Syndrome and Lennox-Gastaut Syndrome							

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.

Comprehensive Management of Dravet Syndrome

Experts in the diagnosis and treatment of Alzheimer disease discuss the recent approval of aducanumab, its implications on the field, and other promising therapies and diagnostic technologies in development. 

Recent Breakthroughs in the Treatment of Alzheimer Disease

Elizabeth Thiele, MD, PhD, and Peter Crino, MD, PhD, discuss the diagnosis and management of tuberous sclerosis complex (TSC) as well as unmet needs in the field.

Management of Tuberous Sclerosis Complex

Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, discuss how dystrophin relates to Duchenne Muscular Dystrophy, current approved therapies, and treatments in development.

Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy

A discussion regarding the stigma associated with migraine and the importance of empowering patients and health care professionals to become involved in migraine advocacy. 

The Patient-Centered Visit & Shared Decision Making in the Management of Migraine

Experts in neurology Laxman Bahroo, DO and Mindy K. Bixby, DO share insights into the diagnosis, management, and treatment of OFF episodes in Parkinson’s disease and highlight key therapeutic options currently available and in development.

Managing OFF Episodes in Parkinson’s Disease

Phyllis Zee, MD, PhD, and Alon Avidan, MD, MPH, provide an overview of behavioral and pharmacological approaches to the management of excessive daytime sleepiness (EDS) and narcolepsy and discuss the recent approval of agents with new mechanisms of action. 

Treating Narcolepsy and Excessive Daytime Sleepiness

Experts review the challenges of managing OFF episodes in Parkinson's disease and the current treatment options to optimize therapy. 